Loading...
NPI 1447925516 · Southlake, TX · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Southlake Diagnostics Inc is a clinical medical laboratory provider located in Southlake, Texas. This profile covers 4 Medicare and 5 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Southlake Diagnostics Inc |
| Address | 580 Commerce St Ste 150a |
| City | Southlake |
| State | TX |
| ZIP | 76092 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | August 11, 2021 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $34.7K |
| Medicaid | $6.4K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 86409 | The lab analyst performs the technical lab test to analyze the titer (concentration) of neutralizing antibodies in a specimen such as plasma. The level of these antibodies indicates a past infection… | 190 | $100 | $20K |
| 86408 | The lab analyst performs the technical lab test to screen a specimen such as plasma for neutralizing antibodies that develop against severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), the… | 190 | $40 | $7.9K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 200 | $20 | $4.6K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 190 | $10 | $2.1K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 4 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 86409 | The lab analyst performs the technical lab test to analyze the titer (concentration) of neutralizing antibodies in a specimen such as plasma. The level of these antibodies indicates a past infection… | 500 | $10 | $4.5K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 520 | $1 | $1K |
| 86408 | The lab analyst performs the technical lab test to screen a specimen such as plasma for neutralizing antibodies that develop against severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), the… | 280 | $1 | $840 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 210 | $1 | $210 |
| 86769 | The lab analyst performs a multiple–step immunoassay to evaluate the patient’s serum for antibodies to severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), which causes coronavirus disease… | 530 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Texas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Texas median
5 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 86769 | The lab analyst performs a multiple–step immunoassay to evaluate the patient’s serum for antibodies to severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), which causes coronavirus disease… | 19 | 80 | 110 | $30 | $29.7K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 118 | 340 | 220 | $10 | $24.1K |
| 86409 | The lab analyst performs the technical lab test to analyze the titer (concentration) of neutralizing antibodies in a specimen such as plasma. The level of these antibodies indicates a past infection… | 1 | 10 | 180 | $40 | $9.6K |
| 86408 | The lab analyst performs the technical lab test to screen a specimen such as plasma for neutralizing antibodies that develop against severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), the… | 1 | 10 | 230 | $1 | $940 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 34 | 60 | 590 | $1 | $230 |
Other providers in the same ZIP code as Southlake Diagnostics Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| C&l Esperanza Home Health Inc | TX | Personal Care Attendant | $0 | $14.8M |
| Jawad Qureshi | TX | Ophthalmology Physician | $7.6M | $1.7K |
| Johnathan Warminski | TX | Ophthalmology Physician | $3.5M | $0 |
| Choice Diagnostic Lab | TX | Clinical Medical Laboratory | $1.7M | $0 |
| Axis Surgery Center, LLC | TX | Ambulatory Surgical Clinic/Center | $1.1M | $0 |
| Lone Star Endoscopy Center, LLC | TX | Ambulatory Surgical Clinic/Center | $941.5K | $0 |
| Jennifer Mcintosh | TX | Family Nurse Practitioner | $886.8K | $0 |
| Health Imaging Partners, LLC | TX | Physiological Laboratory | $845.6K | $0 |
| Rene Leon | TX | Allergy Physician | $785.9K | $0 |
| Musa Abdelaziz | TX | Retina Specialist (Ophthalmology) Physician | $693.1K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.